טוען...
Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy
[Image: see text] A combination of platinum drugs with immunotherapy has shown promising anticancer effects, especially in the drug resistance cancer model. Herein, a new type of immunochemotherapeutic was designed by tethering the toll-like receptor 7 (TLR7) agonist on the axial position of oxalipl...
שמור ב:
| הוצא לאור ב: | ACS Omega |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Chemical
Society
2019
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6964279/ https://ncbi.nlm.nih.gov/pubmed/31956823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b03381 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|